Taiwan FDA registration c54ecf5bf4f0e12061c158fc33983d32
Beckman Coulter IO detects CD3-FITC/CD8-PE monoclonal antibodies
TW: 貝克曼庫爾特IO檢測CD3-FITC/CD8-PE單株抗體
Taiwan·Risk Class 2·IMMUNOTECH SAS, A BECKMAN COULTER COMPANY·Registered Sep 29, 2006 – Sep 29, 2026ActiveRegistration details
- Analysis ID
- c54ecf5bf4f0e12061c158fc33983d32
- Customs Code
- DHA00601755609
Company information
- Manufacturer
- IMMUNOTECH SAS, A BECKMAN COULTER COMPANY
- Manufacturer Country
- France
- Authorized Representative
- BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This fluorescently calibrated antibody cocktail is suitable for multiplex analysis using flow cytometry. It allows detection of CD3 and CD8 antigen manifestations on white blood cells.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.5220 Automatic Differentiation Cell Counter
- Import Information
- import
Dates and status
- Registration Date
- Sep 29, 2006
- Expiry Date
- Sep 29, 2026
About this record
Access comprehensive regulatory information for Beckman Coulter IO detects CD3-FITC/CD8-PE monoclonal antibodies in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c54ecf5bf4f0e12061c158fc33983d32 and manufactured by IMMUNOTECH SAS, A BECKMAN COULTER COMPANY. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices